12.43USD+1.64%Mkt Cap: 197.51M USDP/E: —Last update: 2026-06-01
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, an…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap197.51M USD
Enterprise Value12.37M USD
Revenue (TTM)17.56M USD
Gross Profit6.47M USD
Net Income (TTM)-124.02M USD
Revenue/Share1.679 USD
Last Price12.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.58
PEG—
EV/EBITDA-0.08
EV/Revenue0.70
P/S11.20
P/B0.64
EPS (TTM)-14.66
EPS (Forward)-7.80
52W Range
11.601% of range69.97
52W High69.97 USD
52W Low11.60 USD
Profitability
Gross Margin49.34%
Oper. Margin-603.91%
EBITDA Margin0.00%
Profit Margin-946.22%
ROE-50.59%
ROA-44.75%
Growth
Revenue Growth183.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-99.84M USD
CapEx (TTM)3.37M USD
FCF Margin-437.05%
FCF Yield-38.85%
Net Debt-184.18M USD
Net Debt/EBITDA1.23
Balance Sheet
Debt/Equity0.01
Current Ratio6.99
Quick Ratio6.57
Book Value/Sh19.17 USD
Cash/Share11.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 1, 2019
Splits
Last Split1:100
Split DateFeb 5, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)46.25 USD
Target Range22.00 USD – 65.00 USD
# Analysts4
Ownership
Shares Out.15.94M
Float15.92M
Insiders0.13%
Institutions41.42%
Short Interest
Short Ratio5.7d
Short % Float14.71%
Short % Out.14.70%
Shares Short2.34M
Short (prev mo.)2.48M
Technical
SMA 5013.62 (-8.7%)
SMA 20018.74 (-33.7%)
Beta1.69
S&P 52W Chg27.70%
Avg Vol (30d)394.35K
Avg Vol (10d)489.20K
Technical Indicators
RSI (14)42.2
MACD-0.2635
MACD Signal-0.0546
MACD Hist.-0.2088
BB Upper15.38 USD
BB Middle13.63 USD
BB Lower11.88 USD
BB Width25.69%
ATR (14)1.013 USD
Vol Ratio (20d)0.75x